tiprankstipranks
Sangamo Therapeutics (SGMO)
NASDAQ:SGMO
US Market
SGMO
Sangamo Therapeutics
RESEARCH TOOLSreports

Sangamo Therapeutics (SGMO) Stock News & Sentiment

2,627 Followers
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
12h ago
IMA
VTI
Why Is Vanguard Total Stock Market ETF (VTI) Up Today, 4/10/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Up Today, 4/10/2026?
3d ago
CAR
HTZ
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/9/26?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/9/26?
4d ago
CAR
IMA
Why Is Vanguard Total Stock Market ETF (VTI) Rising Today, 4/8/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Rising Today, 4/8/2026?
6d ago
CAR
IMA
Sangamo Therapeutics: Partnering-Driven Path to 2027 Fabry Gene Therapy Launch Supports Buy Rating and $10 Target
Premium
Ratings
Sangamo Therapeutics: Partnering-Driven Path to 2027 Fabry Gene Therapy Launch Supports Buy Rating and $10 Target
11d ago
SGMO
Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty
Premium
Company Announcements
Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty
13d ago
SGMO
Sangamo Biosciences Balances Fabry Progress With Cash Risk
Premium
Company Announcements
Sangamo Biosciences Balances Fabry Progress With Cash Risk
13d ago
SGMO
More SGMO News >

SGMO News on the Web

Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
TipRanks News
Neutral
Why Is Vanguard Total Stock Market ETF (VTI) Up Today, 4/10/2026?
TipRanks News
Neutral
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/9/26?
TipRanks News
Neutral
Why Is Vanguard Total Stock Market ETF (VTI) Rising Today, 4/8/2026?
TipRanks News
Neutral
Sangamo Therapeutics: Partnering-Driven Path to 2027 Fabry Gene Therapy Launch Supports Buy Rating and $10 Target
TipRanks News
Bullish
Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty
TipRanks News
Bearish
Sangamo Biosciences Balances Fabry Progress With Cash Risk
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Terns Pharmaceuticals (TERN), Sangamo Therapeutics (SGMO) and Galectin Therapeutics (GALT)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
SGMO
Sector Average
Media Buzz
This Week4 articles
Weekly Average5 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SGMO’s Media Buzz Sentiment?
4 articles about SGMO were published this week. In an average week, 5 articles are published.
    What is SGMO’s weekly average amount of articles?
    In an average week, 5 articles about SGMO are published.
      What is SGMO’s News Sentiment?
      50% of articles about SGMO were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        STAAStaar Surgical
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week